will enlist 600 patients to determine the effectiveness of chloroquine as a
valid COVID-19 treatment. The disclosure was made by state’s Information
Commissioner, Gbenga Omotosho.
to look at about 600 patients. The trial continues until we recruit the number
will be formed. The board may request that the research be stopped if the
statistical evidence of a drug ‘s usefulness is overwhelming and in which case
it becomes unethical to withhold it from other groups.
Babajide Sanwo-Olu, said that the state had learned how to deal with infectious
diseases by handling infectious diseases through its handling of the Ebola
pandemic in 2014.
it gave Lagos some understanding on how to manage serious infectious diseases.
We have an Infectious Disease Hospital in Yaba and we have had some
international grants even after the Ebola case and over the past two to three
years we have built what we call a biosecurity lab level four that can match
any of its kind in the world.
Health, Akin Abayomi, had earlier in April said the state was going to hold
clinical trials. The adaptation of Chloroquine for clinical trial as a
potential drug in managing the symptoms of COVID-19 is based on data from other
treatment centres across the world.